Altimmune, Inc. ( ALT) - Key Metrics

ALT Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $0 -$0.12 -$0.13 -$0.13
2026Q1 $0 -$0.18 -$0.17 -$0.17
2025Q4 $0 -$0.27 -$0.19 -$0.19
2025Q3 $0 -$0.21 -$0.13 -$0.13
2025Q2 $0 -$0.27 -$0.24 -$0.24

ALT Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% -6.33
2026Q1 0% -4.28
2025Q4 0% -3.34
2025Q3 0% -4.49
2025Q2 0% -3.58

ALT

Price: $3

52 week price:
2.56
6.44

Payout Ratio Range:
-9112.33%
-2267.61%

Earnings Per Share: -0.76 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 680703

Ebitda: -31.4 million

Market Capitalization: 571.9 million

Links: